Paclitaxel hypersensitivity reactions: a role for docetaxel substitution.
Lokich
J
J
Anderson
N
N
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000077143:Docetaxel; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D005260:Female; D005990:Glycerol / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; C000515:cremophor EL; D017239:Paclitaxel; D005990:Glycerol